Journal of pharmaceutical research and drug design (Jprd)
Aim and Scope
Journal of Pharmaceutical Research and Drug Design (JPRD) aims at rapid publication of high quality results in the field of Pharmaceutical while maintaining rigorous peer-review process. All accepted papers will be appeared online immediately.
JPRD encourages submission of manuscripts related to (but not limited to) synthesis and processing of pharmaceuticals, molecular modeling, rational drug design
Dosage form design
Targeted drug delivery
Stability of drugs
Standardization and evaluation of raw materials and formulations
Adverse drug reactions
Therapeutic drug monitoring
Metabolic disposition of bioactive agents
Publication of article types:
Original research articles: Describes original research within the scope of the journal.
Case reports: Reports of clinical presentations describing a diagnostic or therapeutic dilemma followed by evaluative studies
Editorial comments: Introduce current research and comment on major advances and developments in the field.
Methodology: Present a new experimental method, test or procedure. The methods described may be completely new or a better version of already existing one. The method should demonstrate all the possible tests and results.
Rapid communications: Short papers presenting highly significant and original material.
Review articles: To review the progression of a research in the field and make suggestions for future work includes authoritative, comprehensive, descriptions of any subject within the scope of Dentistry & Oral Health journal.
Letters to the editor: Letter consisting of comments directly on publications of journal which are already published or introduces a specific issue of a general interest.
As Journal of Pharmaceutical Research and Drug Design follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online and JPRD will be kept up to date with latest advances in the field of Drug Design. All published articles will be assigned with unique Digital Objective Identifier provided by Cross Ref.